Blackstone-Affiliated Entities Sell Over $1.1 Billion in Medline Shares

summarizeSummary

Blackstone-affiliated 10% owners disposed of over 28 million shares of Medline Inc. Class A Common Stock for approximately $1.14 billion as part of a previously announced secondary offering.

check_boxKey Events

• Major Share Disposition

  Blackstone-affiliated 10% owners, including BX Mozart ML-2 Holdco L.P., sold 27,852,986 shares of Class A Common Stock in open market transactions.

• Significant Proceeds

  The open market sales generated approximately $1,128,268,757 at an average price of $40.51 per share on March 10, 2026.

• Part of Secondary Offering

  This sale is part of the secondary offering of 75 million shares by major private equity shareholders, which was priced on March 5, 2026, and closed on March 10, 2026.

• Additional In-Kind Distribution

  An additional 366,337 shares were disposed of via in-kind distributions to investors, as detailed in the filing.

auto_awesomeAnalysis

This Form 4 details the specific execution of a significant portion of the recently closed secondary offering by Blackstone-affiliated entities, which are major 10% owners. The open market sale of approximately $1.13 billion in shares, representing about 2.1% of Medline's market capitalization, indicates a substantial reduction in their stake. This follows the broader trend of private equity firms, including Carlyle and Hellman & Friedman, monetizing their investments in Medline Inc. following its IPO. While expected as part of the secondary offering, the sheer scale of the disposition by these institutional investors could contribute to an overhang on the stock.